Wilson et al., 2022 - Google Patents
Innovative technological advancements in laboratory medicine: Predicting the lab of the futureWilson et al., 2022
View PDF- Document ID
- 17540911379214489418
- Author
- Wilson S
- Steele S
- Adeli K
- Publication year
- Publication venue
- Biotechnology & Biotechnological Equipment
External Links
Snippet
Laboratory medicine is integral to public health and healthcare provision, and it relies on numerous analytical techniques to provide timely, objective data to healthcare professionals to guide disease prevention, diagnosis, treatment, and monitoring. Driven and defined by a …
- 239000003814 drug 0 title abstract description 69
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Microfluidic point-of-care (POC) devices in early diagnosis: A review of opportunities and challenges | |
| Dincer et al. | Multiplexed point-of-care testing–xPOCT | |
| Otoo et al. | REASSURED multiplex diagnostics: a critical review and forecast | |
| Wilson et al. | Innovative technological advancements in laboratory medicine: Predicting the lab of the future | |
| Gupta et al. | Point-of-care PCR assays for COVID-19 detection | |
| Nahavandi et al. | Microfluidic platforms for biomarker analysis | |
| Zhang et al. | Digital bioassays: theory, applications, and perspectives | |
| Ahmed et al. | Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine | |
| Chen et al. | Single-cell analysis at the threshold | |
| Byrnes et al. | Wash-free, digital immunoassay in polydisperse droplets | |
| Araz et al. | Microfluidic multiplexing in bioanalyses | |
| Lopez-Barbosa et al. | The future point-of-care detection of disease and its data capture and handling | |
| Liu et al. | Microfluidic platforms for single-cell protein analysis | |
| Zec et al. | Novel droplet platforms for the detection of disease biomarkers | |
| Yang et al. | Microfluidic magnetic analyte delivery technique for separation, enrichment, and fluorescence detection of ultratrace biomarkers | |
| Yin et al. | Microfluidics-based POCT for SARS-CoV-2 diagnostics | |
| Kelley | Advancing ultrasensitive molecular and cellular analysis methods to speed and simplify the diagnosis of disease | |
| Khosla et al. | Simplifying the complex: accessible microfluidic solutions for contemporary processes within in vitro diagnostics | |
| Nichols et al. | Sample preparation and diagnostic methods for a variety of settings: A comprehensive review | |
| Orton et al. | Proteomic workflows for biomarker identification using mass spectrometry—technical and statistical considerations during initial discovery | |
| Chavez‐Pineda et al. | Microfluidic systems for the analysis of blood‐derived molecular biomarkers | |
| Piorino et al. | Low-cost, point-of-care biomarker quantification | |
| Kim | Overview of the microfluidic diagnostics commercial landscape | |
| Hu et al. | DropLab: an automated magnetic digital microfluidic platform for sample-to-answer point-of-care testing—development and application to quantitative immunodiagnostics | |
| Escobar et al. | Integrated microfluidic-based platforms for on-site detection and quantification of infectious pathogens: Towards on-site medical translation of SARS-CoV-2 diagnostic platforms |